Detailed answers about INVENTIVE MEDICAL SOLUTIONS LIMITED, including incorporation, status, business activity, and accounts information.
When was INVENTIVE MEDICAL SOLUTIONS LIMITED founded?
INVENTIVE MEDICAL SOLUTIONS LIMITED was officially incorporated on 17 September 2016 and is registered under company number 10381944. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is INVENTIVE MEDICAL SOLUTIONS LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of INVENTIVE MEDICAL SOLUTIONS LIMITED?
INVENTIVE MEDICAL SOLUTIONS LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does INVENTIVE MEDICAL SOLUTIONS LIMITED do?
INVENTIVE MEDICAL SOLUTIONS LIMITED operates in the following sectors: 46460 - Wholesale of pharmaceutical goods, 72110 - Research and experimental development on biotechnology, 74909 - Other professional, scientific and technical activities n.e.c.. These SIC codes provide insight into the company's business activities and industry focus.
What is INVENTIVE MEDICAL SOLUTIONS LIMITED's registered address?
The registered office address of INVENTIVE MEDICAL SOLUTIONS LIMITED is 128 CITY ROAD, LONDON, UNITED KINGDOM, EC1V 2NX. This is the official address filed with Companies House for legal and statutory correspondence.
Is INVENTIVE MEDICAL SOLUTIONS LIMITED financially stable?
The most recent accounts for INVENTIVE MEDICAL SOLUTIONS LIMITED were made up to 30 September 2024, filed as MICRO ENTITY. Next accounts are due by 30 June 2026.